Kyntra Bio, Inc. Common Stock

KYNBNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
7.13 USD
↗ 0.37 (5.47%)AT CLOSE (11:59 AM EDT)
7.04
↘ 0.09 (1.26%)
POST MARKET (AS OF 07:27 PM EDT)
Post Market
AS OF 07:27 PM EDT
7.04
↘ 0.09 (1.26%)
🔴Market: CLOSED

Kyntra Bio, Inc. Common Stock (KYNB) trades at $7.13 per share. Technical indicators currently signal "Buy". Key drivers include negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, KYNB appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 12, 2026.

Open?$6.80
High?$7.95
Low?$6.72
Prev. Close?$6.76
Volume?461.4K
Avg. Volume?23.9K
VWAP?$7.20
Rel. Volume?19.27x
Bid / Ask
Bid?$5.93 × 100
Ask?$8.38 × 100
Spread?$2.45
Midpoint?$7.16
Valuation & Ratios
Market Cap?28.9M
Shares Out?4.0M
Float?3.9M
Float %?95.7%
P/E Ratio?0.18
P/B Ratio?-0.66
EPS?$40.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Rare Disease Therapeutics
Employees
34
Market Cap
28.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.kyntrabio.com
Listed
2014-11-14
Address
350 BAY STREET
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?3.00%Low
Short Interest?116.4K
Days to Cover?14.8
Free Float3.9M
Avg Daily Volume7.8K
Settlement Date2026-05-29
Financial Health
Current Ratio?3.61Strong
Quick Ratio?3.48Strong
Cash Ratio?1.32Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
93/100
P/E?
Peers
100
S&P
97
0.2CHEAP▾
P/B?
S&P
97
-0.66CHEAP▾
P/S?
Peers
100
S&P
39
3.88FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.2CHEAP▾
EV/Sales?
S&P
97
-1.09CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-373.5%WEAK▾
ROA?
Peers
50
S&P
97
149.2%STRONG▾
Cash Flow & Enterprise
FCF?$-21402000
Enterprise Value?$-8133961
Fundamentals ratios updated end of day
MarketsMoversWatchlist